Subtypes of adolescents with substance use disorders and psychiatric comorbidity using cluster and discriminant analysis of MMPI-A profiles by Magallón Neri, Ernesto Mijail et al.
Resumen Abstract
219ADICCIONES, 2012 · VOL. 24 NÚM. 3 · PÁGS. 219-228
The main aim of this study was to replicate and extend previous 
results on subtypes of adolescents with substance use disorders (SUD), 
according to their Minnesota Multiphasic Personality Inventory for 
adolescents (MMPI-A) profiles. Sixty patients with SUD and psychiatric 
comorbidity (41.7% male, mean age = 15.9 years old) completed the 
MMPI-A, the Teen Addiction Severity Index (T-ASI), the Child Behaviour 
Checklist (CBCL), and were interviewed in order to determine DSM-
IV diagnoses and level of substance use. Mean MMPI-A personality 
profile showed moderate peaks in Psychopathic Deviate, Depression 
and Hysteria scales. Hierarchical cluster analysis revealed four profiles 
(acting-out, 35% of the sample; disorganized-conflictive, 15%; 
normative-impulsive, 15%; and deceptive-concealed, 35%). External 
correlates were found between cluster 1, CBCL externalizing symptoms 
at a clinical level and conduct disorders, and between cluster 2 and 
mixed CBCL internalized/externalized symptoms at a clinical level. 
Discriminant analysis showed that Depression, Psychopathic Deviate 
and Psychasthenia MMPI-A scales correctly classified 90% of the 
patients into the clusters obtained. 
Key words: substance use disorder (SUD), MMPI-A, hierarchical cluster 
analysis, discriminant analysis, adolescents.
El objetivo principal de este estudio fue replicar y ampliar los resulta-
dos de estudios previos sobre subtipos de adolescentes con trastorno 
por uso de sustancias (TUS), de acuerdo con sus perfiles de persona-
lidad en el Minnesota Multiphasic Personality Inventory for adoles-
cents (MMPI-A). Sesenta pacientes con TUS y comorbilidad psiquiátrica 
(41.7% hombres, edad media = 15.9 años) completaron el MMPI-A, 
el Teen Addiction Severity Index (T-ASI), el Child Behaviour Checklist 
(CBCL), y entrevistas para obtener diagnósticos DSM-IV y medidas del 
nivel de uso de sustancias. El perfil general de personalidad MMPI-A 
mostró elevaciones moderadas en las escalas de Desviación Psicopáti-
ca, Depresión e Histeria. El análisis de cluster jerárquico reveló cuatro 
perfiles (acting-out, 35% de la muestra;  disorganized-conflictive, 15%; 
normative-impulsive, 15%; y deceptive-concealed, 35%). Se encontra-
ron asociaciones entre el cluster 1, la sintomatología externalizante a 
nivel clínico del CBCL y los trastornos de conducta, así como entre el 
cluster 2 y un nivel clínico de síntomas internalizantes y externalizantes 
del CBCL. El análisis discriminante mostró que las escalas del MMPI-A 
Depresión, Desviación Psicopática y Psicastenia, clasificaron correcta-
mente el 90% de los pacientes dentro de los subgrupos obtenidos.
Palabras clave: trastorno por uso de sustancias (TUS), MMPI-A, análisis 
de cluster jerárquico, análisis discriminante, adolescentes. 
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In adolescents, substance use disorders (SUD) are asso-ciated with a wide variety of psychological, social and interpersonal problems that make intervention particu-
larly complex and often produce poor treatment outcomes 
(Hawkins, 2009; Waldron & Turner, 2008), especially in ado-
lescents with comorbid psychiatric disorders (Couwenbergh, 
Van den Brink, Zwart, Vreugdenhil, Van Wijngaarden-Cremers 
& Van der Gaag, 2006). Indeed, the increase in dual disorders 
among adolescents is becoming a major health problem, not 
only for the individuals and families concerned but at the 
community level as well, since it generates a high social cost 
(EMCDDA, 2010; Martino, Carroll, Kostas, Perkins & Roun-
saville, 2002).
Substance use disorders have been associated with both 
internalizing and externalizing symptoms (King, Iacono &
McGue, 2004; Martel, Pierce, Nigg, Jester, Adams, Puttler et 
al. 2009), and particularly with antisocial tendencies, depres-
sion, emotional dysregulation and lack of impulse control 
(Kirisci, Tarter, Mezzich & Vanyukov, 2007; Muñoz-Rivas, 
Graña, Peña & Andreu, 2002). Comorbidity between SUD 
and other psychiatric diagnoses increases the risk of unpro-
tected sexual intercourse, suicide, violence and delinquency, 
among other negative consequences (Estévez & Emler, 2011; 
Hawkins, 2009). Given the special complexity of treating 
dual disorders in adolescents, several authors have recently 
emphasized the need to integrate both mental health and 
substance use components into treatment in a coordinated 
and flexible way (Hawkins, 2009; Waldron & Turner, 2008). 
The analysis of subtypes of adolescents with SUD and comor-
bid diagnoses according to personality traits is an understud-
ied field, and greater knowledge in this regard could help to 
design different treatments for different types of patients 
(Conrod, Castellanos-Ryan & Strang, 2010).
The MMPI (Minnesota Multiphasic Personality Inventory) 
is one of the most widely used instruments to assess person-
ality and psychopathology in the field of SUD, the version 
for adolescents and youngsters (MMPI-A; Butcher, Williams, 
Graham, Archer, Tellegen, Ben-Porath et al., 1992), is also 
used for assessment both in clinical and correctional contexts 
(Archer, 2005; Stein & Graham, 2005). Both instruments 
basically comprise three validity scales [Lie (L), Infrequency 
(F) and Defensiveness (K)] and ten clinical scales [Hypochon-
driasis (1 Hs), Depression (2 D), Hysteria (3 Hy), Psychopathic 
Deviate (4 Pd), Masculinity-Femininity (5 Mf), Paranoia (6 
Pa), Psychasthenia (7 Pt), Schizophrenia (8 Sc), Hypomania 
(9 Ma), and Social Introversion (0 Si)]. The MMPI-A includes 
two additional drug-related scales, which complement the 
earlier MacAndrew Alcoholism-Revised scale (MAC-R). These 
two scales are the Alcohol/Drug Problem Acknowledgment 
(ACK) scale, which identifies self-recognition of problems 
related to drugs (obvious items), and the Alcohol/Drug Prob-
lem Proneness (PRO) scale, which identifies susceptibility to 
developing drug problems (subtle items). Both scales have 
been validated and may be of great help in designing indi-
vidualized SUD treatment plans, as they provide information 
related to patients’ insight into their substance use problems 
and their motivation to change (Gallucci, 1997; Micucci, 
2002; Stein & Graham, 2005).
Although there are several studies of MMPI and MMPI-A 
personality profiles in adolescents and young adults (Espel-
age, Cauffman, Broidy, Piquero, Mazerolle & Steiner, 2003; 
Mohíno, Kirchner & Forns, 2008), as well as in patients with 
SUD (Gallucci, 1997; Walfish, Massey & Krone, 1990), only 
two studies have attempted to identify specific subgroups of 
adolescents with SUD through the MMPI (Massey, Walfish 
& Krone, 1992) or the MMPI-A (Passetti, 2002). Both stud-
ies used clustering methods and were conducted mostly with 
Caucasian (93% and 75% respectively) males (66% and 76% 
respectively) initiating residential treatment, and who had 
mainly been referred from the court system. In both sam-
ples the primary drug of choice was cannabis (69% and 89% 
respectively), followed by alcohol (18% and 78% respective-
ly). Neither of these studies specifically addressed clinically-
referred dual disordered patients.
The study by Massey et al. (1992) identified a three-clus-
ter structure in MMPI scales from SUD adolescents: a) the 
first subgroup (16%) showed a high level of psychopathology 
and a wide variety of symptoms, with main peaks on the 1 
Hs and 4 Pd scales, as well as significant elevations on the 8 
Sc, 2 D, 3 Hy and 7 Pt scales; b) the second subgroup (39%) 
showed an impulsive or acting-out personality style, with a 
peak on the 4 Pd scale and significant elevations on the 9 
Ma, 7 Pt and 8 Sc scales; and c) the third subgroup (45%) 
showed non-clinically significant elevations.
Passetti (2002) found a four-cluster structure using the 
MMPI-A. The first cluster (22%) was composed of patients 
with a ‘fake-good’ attitude (minimization of clinical prob-
lems and positive self-presentation), with a moderate-low 
clinical profile peaking on the 4 Pd and 3 Hy scales. The sec-
ond cluster (31%) included apparently sincere patients with 
non-clinical elevations. The third cluster (21%) consisted of 
patients showing broad and intense emotional stress and 
severe psychopathological symptoms, with elevations mainly 
on the 4 Pd, 6 Pa, 8 Sc and 9 Ma scales. The fourth cluster 
(26%) was described as having an impulsive acting-out per-
sonality style, with a peak on the 4 Pd scale and moderate-
to-high levels of emotional distress.
The present study has three aims. First, to replicate and 
extend previous findings about typologies of adolescents 
with SUD by applying cluster and discriminant analysis 
methods to MMPI-A scores of dual diagnosed adolescents. 
Second, to explore the external validity of the clusters identi-
fied by comparing the respective patterns of substance use, 
diagnostic categories, externalizing and internalizing symp-
toms, and the severity of drug-related problems. Thirdly, to 
compare the mean scores of the different clusters on the 
MMPI-A drug-related scales (MAC-R, ACK and PRO). 
On the basis of previous studies, we expected to find 
a general MMPI-A profile with a peak on the 4 Pd scale 
(Walfish et al., 1990) and moderate-to-significant elevations 
on the 2 D, 3 Hy and 9 Ma scales (Gallucci, 1997). Addi-
tionally, we expected to find a cluster distribution similar to 
that of Passetti (2002), who also used the specific instrument 
for adolescents (MMPI-A). We hypothesized there would be 
congruent external clinical correlates (diagnoses and CBCL 
symptoms) for some of the clusters found (Passetti, 2002). 
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Finally, we expected that some of the clusters would show 
a high score on the drug-related ACK scale, indicating an 
overt recognition of drug problems, while other clusters 
would obtain a lower score on ACK in comparison with PRO, 
showing a predisposition towards drug problems with a low 
insight (Micucci, 2002).
Method
Participants
Potential subjects for this study were patients consecu-
tively admitted to the Adolescent Addictive Behaviour Unit 
of the Child and Adolescent Psychiatry and Psychology 
Department of an urban, public general hospital between 
September 2006 and March 2008. In this unit most patients 
are treated as outpatients, although approximately 30% 
need short periods as inpatients on the psychiatric ward or 
in the day-care hospital in order to treat acute psychiatric 
symptoms or to help them break their drug habit.
The following criteria were defined for participation 
in the study. Inclusion criteria: age 13-18 years, meeting 
DSM-IV-TR (APA, 2002) diagnostic criteria for SUD (abuse 
and/or dependence) and signing informed consent forms. 
Exclusion criteria: presence of functional mental retarda-
tion or acute psychopathological disturbances (psychotic 
state, severe depression). All the participants in this study, 
met criteria for at least one SUD (mainly related to alcohol 
and cannabis use), although not all of them reached a SUD 
level in each of the assessed substances. Patients presenting 
with acute psychopatological disturbances (severe psychotic 
state or depression) during the first month of intervention 
in the UNICA-A were excluded, because of potential inter-
ference effect in the psychological evaluation. However, this 
did not exclude patients diagnosed with stabilized non-acute 
depression or psychotic disorders of participating in this 
study. 
Out of a total of 91 SUD patients admitted for treatment 
to the Adolescent Addictive Behaviour Unit, 84 fulfilled the 
inclusion criteria. Seven of them refused to complete a sig-
nificant portion of the evaluation protocol and 11 patients 
were referred for more intensive treatment in a residential 
centre before finishing the evaluation. A further six subjects 
were excluded from the final statistical analysis because of 
invalid MMPI-A profiles, due to a T score >65 on either L (Lie) 
or K (Defensiveness) scales. Consequently, 60 patients were 
included in the final analysis (41.7% male, mean age 15.9, 
SD = 1.20, range 13-18 years old). Although a comprehensive 
analysis of patients’ profile among excluded patients was 
not feasible, we reported a higher frecuency of male sub-
jects (68.0 vs 41.7% in the included subjects) among them. 
Primary comorbid diagnosis of attention deficit hyperactive 
disorder (36.0% vs. 20%) or conduct disorder (28.0 vs.15.0%) 
was more prevalent among excluded patients, too, whereas 
no significant differences in age (mean age 15.9, SD = 1.24 
years old) were found.
Instruments
Psychiatric diagnosis. Initial diagnoses were based on the 
Spanish version of the Kiddie-SADS semi-structured diagnos-
tic interview for children and adolescents. This instrument 
has shown good reliability and validity for present and life-
time disorders, as well as good internal consistency (Ulloa, 
Ortiz, Higuera, Nogales, Fresán, Apiquian, et al., 2006). All 
the subjects were diagnosed by the clinical staff of the child 
and adolescent psychiatry department of a urban public hos-
pital, according to DSM-IV-TR criteria. 
Socio-demographic data. Data regarding age, gender 
and socio-economic status were obtained through semi-
structured interviews adapted to Spanish (Díaz, Castro-
Fornieles, Serrano, González, Calvo, Goti et al., 2008) from 
those used in the Collaborative Study on Genetics of Alcohol-
ism (Hesselbrock, Easton, Bucholz, Schuckit & Hesselbrock, 
1999). 
Level of substance use. All the subjects fulfilled crite-
ria for at least one SUD. However, it was considered relevant 
to identify the pattern of use of other subtances. According 
to the quantity/frequency of use gathered from the semi-
structured interviews mentioned above (Díaz et al., 2008), 
the level of use of each drug (tobacco, alcohol, cannabis, 
cocaine, amphetamine derivatives, and others) was coded 
into five ordinal categories: 1) No use; 2) Occasional use: 
at parties, during holidays or special celebrations; 3) Regu-
lar use: several times a week for tobacco, almost weekly for 
alcohol or cannabis, almost monthly for other illegal drugs, 
with no evidence of drug-related problems; 4) SUP (Sub-
stance Use Problems): quantity-frequency and/or situational 
pattern of drug use which generates some health or psycho-
social problems but still sub-diagnostic (according to Shrier, 
Harris, Kurland & Knight, 2003); and 5) SUD: a definite diag-
nosis of abuse or dependence according to DSM-IV-TR crite-
ria (APA, 2002).
Personality. The Spanish version of the MMPI-A, which 
shows acceptable psychometric properties (Jiménez-Gómez 
& Ávila-Espada, 2003), was administered. This instrument 
contains 478 items assessing personality characteristics 
and psychopathological symptoms in adolescents. T scores 
above 65 are considered clinically significant, while T scores 
between 60 and 65 are considered moderately significant or 
‘sub-threshold’ (Micucci, 2002; Passetti, 2002; Stein & Gra-
ham, 2005).
Severity of addiction. The 142-item Spanish version of 
the T-ASI (Teen-Addiction Severity Index) (Díaz et al., 2008) 
assesses the severity of problems arising from substance use 
in seven domains: drug use, school status, employment prob-
lems, family function, peer/social relationships, legal status 
and psychiatric status, each of which is scored using a five 
point scale (0 = None, 1 = A little, 2 = Fair amount, 3 = 
Very much, 4 = Extremely/Always). It has been shown to have 
good reliability and validity in different language versions 
(Kaminer, 2008). As most of the patients were unemployed 
during the study period, data relating to the employment 
subscale were not considered in the analysis.
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Behavioural and emotional symptoms. A Spanish ver-
sion of the original Child Behaviour Checklist (CBCL) (Achen-
bach, 1991) was completed by parents to assess adolescent 
psychopathological symptoms. It consists of two parts: the 
first assesses social competence through 20 items, the sec-
ond consists of 120 items related to emotional symptoms 
or behavioral problems that have occurred in the last 6 
months. The respondent evaluates each item on a Likert scale 
from 0 (not true) to 2 (very often true). The CBCL counts of 
eight narrow band scales (Anxious/Depressed, Withdrawn/
Depressed, Somatic Complaints, Social Problems, Thought 
Problems, Attention Problems, Rule-Beaking behavior, Agres-
sive behavior) and two broad band scales (internalizing and 
externalizing), and has demonstrated moderate internal 
consistency and good test-retest reliability (Albores-Gallo, 
Lara-Muñoz, Esperón-Vargas, Cárdenas Zetina, Pérez Soriano 
& Villanueva Colin, 2007). For the present analysis, only T
scores for the internalizing (Withdrawn, Somatic Complaints 
and Anxious/Depressed) and externalizing (Delinquent and 
Aggressive Behaviour) scales were used. T scores above 70 
were considered as clinically significant.
Procedure
The MMPI-A and the other parts of the evaluation pro-
tocol were administered by trained staff (holders of Master’s 
or doctoral degrees in clinical psychology) within the first 
month of the patient’s referral to the Addictive Behaviours 
Unit. All adolescents and their parents signed informed con-
sent forms before entering the study, and confidentiality was 
ensured. Data collection and procedures were approved by 
the institutional Ethics Committee. 
Data Analysis
First, a descriptive analysis of the total sample, percent-
ages and frequencies for level substance use and psychiatric 
comorbidity were calculated.  Hierarchical cluster analysis of 
the ten clinical scales of the MMPI-A was performed using 
Ward’s method (Mohíno et al., 2008; Passetti, 2002), based 
on squared Euclidean distances implemented to split the 
group of cases into homogeneous subgroups. The resulting 
clusters were subjected to a MANOVA, in order to obtain the 
statistics associated with the size effect estimation accord-
ing to partial eta-squared (ηp
2) and statistical power (1-β) 
(Ferguson, 2009). At the same time a Scheffé’s post-hoc con-
trast was calculated, using T scores, for each validity, clini-
cal and drug-related scale of the MMPI-A, as well as, the 
internalizing and externalizing CBCL scales, in order to see 
the differences among the clusters. The Kruskal-Wallis H test 
was then used to identify significant differences between 
clusters on T-ASI scales (drug use, school, family, social, legal, 
psychiatric), and levels of substance use, due to the ordi-
nal nature of these variables. The χ2 test was used to com-
pare percentages of psychiatric diagnoses between clusters. 
Fisher’s exact test was run for those psychiatric disorders for 
which the underlying χ2 assumptions were violated. Finally, a 
discriminant analysis was applied in order to identify which 
of the ten MMPI-A clinical scales had the greatest predictive 
value as regards determining cluster membership. All statisti-
cal analyses were performed using SPSS 16.0 and the level of 
significance was set at p ≤ 0.05.
Results
Substance use and clinical features of the sample
Excluding tobacco (for which 83.3% of patients met cri-
teria for SUP or SUD) the principal drug of abuse was can-
nabis (85% SUP or SUD), followed by alcohol (43.3% SUP 
or SUD, mainly used in weekend recreational settings), 
amphetamines or derivatives (36.7% used them occasionally) 
and cocaine (11.7% of the patients had used cocaine at least 
once). The comorbid psychiatric diagnoses on Axis I were 28 
(46.7%) adolescents with a diagnosis of conduct disorder 
(CD) or oppositional defiant disorder (ODD), 12 (20.0%) with 
attention deficit hyperactivity disorder (ADHD), 12 (20.0%) 
with eating disorders, 6 (10.0%) with adjustment disorders, 
5 (8.3%) with mood disorders, 5 (8.3%) with non-affective 
psychotic disorders, and 4 (3.3%) with anxiety disorders. On 
Axis II, 12 (20.0%) adolescents met criteria for Cluster B per-
sonality disorders.
Mean scores on MMPI-A scales and cluster pro-
files
The mean MMPI-A clinical profile for the total sample 
showed moderate elevations on the 4 Pd, 2 D and 3 Hy scales 
(see Figure 1). The cluster analysis of the ten MMPI-A clinical 
scales for the 60 subjects yielded two solutions: one of three 
and one of four subgroups. We chose the four subgroups 
solution in accordance with the interpretability of the clus-
ters, basing our decision on previous research and taking into 
account the clinical characteristics of the sample. The four 
clusters obtained with the ten clinical scales also showed 
significant differences on validity and drug-related scales 
(Table 1). The MANOVA analysis was conducted  and differ-
Figure 1.  MMPI-A mean profiles for general sample
and by cluster.
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Table 1. Descriptive and MANOVA analysis for MMPI-A scales among clusters in general SUD sample and the four clusters. 
MMPI-A General SUD Cluster 1 (n=21) Cluster 2 (n=9) Cluster 3 (n=9) Cluster 4 (n=21) MANOVA Scheffé
scales sample “Acting-Out” “Disorganized-Conflictive” “Normative-Impulsive” “Deceptive-concealed” F Snedecor Post-hoc
 (n = 60) Mean (SD) Mean (SD) Mean (SD) Mean (SD) (df = 3,56) comparisions
L 51.25 (9.03) 48.52 (8.22) 44.11 (8.81) 50.78 (8.04) 57.24 (6.87)      7.43 *** 4>2
F 58.97 (11.88) 59.71 (7.80) 77.00 (7.50) 59.11 (7.20) 50.40 (9.40)    21.57 *** 2>1,3,4
K 50.90 (9.67) 50.48 (7.56) 42.11 (8.25) 46.22 (7.87) 57.10 (9.02)      8.33 *** 4>2,3
1  Hs 57.32 (11.01) 58.90 (9.33) 72.44  (6.67) 56.78 (5.80) 49.48 (8.31)    16.95 *** 2>1,3,4 : 1>4
2  D 60.43 (11.48) 67.10 (6.48) 71.11 (11.31) 48.67 (7.51) 54.24 (8.50)    19.88 *** 1,2>3,4
3  Hy 63.45 (10.20) 68.71 (8.06) 72.11 (8.38) 55.00 (5.76) 58.10 (8.70)    12.81 *** 1,2>3,4
4  Pd 64.30 (10.63) 72.43 (7.11) 71.78 (5.71) 57.89 (6.47) 55.71 (7.93)    24.80 *** 1,2>3,4
5  Mf 49.83 (10.32) 51.00 (12.72) 48.89 (4.96) 48.89 (6.91) 49.48 (11.51)      0.14   1,2,3,4
6  Pa 56.50 (10.67) 58.48 (9.91) 70.89 (7.40) 55.67 (6.18) 48.71 (6.26)    17.22 *** 2>1,3,4
7  Pt 54.17 (10.39) 57.57 (5.75) 69.00 (4.24) 56.22 (5.01) 43.52 (6.03)    49.90 *** 2>1,3,4 : 1,3>4
8  Sc 55.55 (11.86) 57.86 (7.86) 72.67 (5.85) 59.56 (6.44) 44.19 (6.56)    38.68 *** 2>1,3,4 : 1,3>4
9  Ma 53.75 (10.65) 54.57 (8.41) 64.67 (13.00) 59.33 (3.46) 45.86 (7.61)    12.41 *** 2>1,4 : 3>4
0  Si 50.05 (9.62) 52.05 (6.68) 59.67 (13.06) 50.44 (8.02) 43.76 (6.89)      8.76 *** 2>4
MAC-R 60.75 (11.34) 62.71 ( 9.98) 66.67 (14.82) 65.67 (9.67) 54.14 (8.95)      4.68 ** 2>4
ACK 62.42  14.10) 63.90 ( 12.96) 76.78 (14.11) 66.22 (10.23) 53.14 (10.23)      9.08 *** 2>4
PRO 63.97 (11.38) 69.33 (10.91) 63.44 (4.44) 60.22 (9.49) 60.43 (13.02)      2.80 * 1,2,3,4
Note.
MMPI-A Scales in T scores ; [Lie (L), Infrequency (F) and Defensiveness (K)] Clinical scales [Hypochondriasis (1 Hs), Depression (2 D), Hysteria (3 Hy), Psychopathic Deviate (4 Pd), Masculinity-
Femininity (5 Mf), Paranoia (6 Pa), Psychasthenia (7 Pt), Schizophrenia (8 Sc), Hypomania (9 Ma), Social Introversion (0 Si), MacAndrew Alcoholism-Revised (MAC-R), Alcohol/Drug Problem 
Acknowledgement (ACK), Alcohol/Drug Problem Proneness (PRO)]; * p <.05; ** p<.010; *** p<.001.
ences beween clusters on each MMPI-A sacles were found. 
The size effect was ranged from moderate to high (ηp
2 from 
.31 to .73), and the statistical power (1-β) was  high (interval 
.87 to .99), except fot 5Mf scale, indicating that differences 
are relevant.
Clinical MMPI-A profiles for each cluster are shown in 
Table 1.
The first cluster comprised 35% of the sample (n = 21, 
mean age = 15.76, SD =1.41) and was characterized by clini-
cally significant T scores on the 4 Pd, 3 Hy, and 2 D scales. 
High scores on these scales indicate patients with antisocial 
behaviour, low impulse control and emotional reactions to 
conflicts with others; therefore, this cluster reflected acting-
out personality style.
The second cluster contained 15% of the sample (n = 9, 
mean age = 15.67, SD = 1.65) and represented the most psy-
chiatrically disturbed profile. Clinical scales 8 Sc, 1 Hs, 3 Hy, 
4 Pd, 2 D and 6 Pa showed T scores above 70, while the 7 Pt 
and 9 Ma scales had T scores between 65 and 70. According-
ly, validity scales showed an inverted ‘V’ configuration with 
a score of T > 75 on the F (Infrequency) scale. Due to this 
broad spectrum of severe clinical symptoms, this cluster was 
labeled disorganized-conflictive. 
The third cluster included 15% of the sample (n = 9, 
mean age = 16.44, SD = 0.88) and showed no clinically sig-
nificant elevations. This profile only presented moderate-
high scores (T 59-60) on 8 Sc and 9 Ma, reflecting a tenden-
cy toward impulsive behaviour, and it was therefore termed 
normative-impulsive.
The fourth subgroup included the remaining 35% of 
the sample (n = 21, mean age = 16.00, SD = 0.83) and was 
characterized, like cluster 3, by a lack of psychopathologi-
cal manifestations. This cluster presented slight elevations 
(T 55-59) on the 3 Hy and 4 Pd scales and a slight trend 
towards high T scores on the validity scales L (Lie) and K 
(Defensiveness), showing a typical ‘fake good’ profile. This 
subgroup was therefore called deceptive-concealed.
Inter-cluster comparison for drug-related scales 
of the MMPI-A (MAC-R, ACK, PRO)
Two of the MMPI-A drug-related scales (MAC-R and ACK) 
showed clear statistically significant differences between 
clusters, with the ACK scale maximizing inter-cluster differ-
ences mainly between cluster 2 and 4 (see Figure 1 and Table 
1). Additionally, the configuration of ACK and PRO scales dif-
fered between clusters: while cluster 1 showed higher scores 
on PRO (clinically significant) and only moderately signifi-
cant in cluster 2, 3 and 4; clusters 2 and 3 showed greater 
scores on ACK (at clinical level in both clusters) (Figure 1).
Inter-cluster comparison in relation to level 
substance use and severity of addiction (T-ASI)
Scores on the T-ASI subscales and the level of use (see 
table 2) of the different substances did not discriminate 
between the four clusters. Nevertheless, all the clusters 
showed at least a mean regular use of alcohol, a mean SUP 
level of use of cannabis, and at least an occasional use of 
other drugs. Additionally, all the clusters showed moderate 
to high psychiatric impairment on the corresponding scale of 
the T-ASI, reflecting the sample’s clinical origin.
Inter-cluster comparison for psychiatric diag-
noses and CBCL scores
Only ODD psychiatric diagnose differed significantly 
between clusters, showing greater prevalence in the first 
cluster (χ2 = 9.42, df = 3;  p = .023). With respect to the CBCL 
(see table 3), there were no significant differences between 
clusters on externalizing or internalizing scales. However, 
two of the clusters showed T scores above 70 (clinical signifi-
cance) on these scales: Cluster 2 on both internalizing (mean 
= 73.38, SD = 5.60) and externalizing (mean = 71.13, SD = 
4.35) scales, and cluster 1 only on the externalizing scale 
(mean = 70.44, SD = 5.98).
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Table 2. T-ASI domains and drug use level by clusters
and global sample.
Variables General Cluster 1 Cluster 2 Cluster 3 Cluster 4
 SUD sample (n=21) (n=9) (n=9) (n=21)
 (n = 60) “Acting- “Disorganized- “Normative- “Deceptive-
  Out” Conflictive” Impulsive” concealed”
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
T-ASI      
Drugs 3.25 (0.87) 3.24 (1.09) 3.33 (0.50) 3.33 (0.70) 3.19 (0.87)
School 2.93 (0.88) 3.10 (0.76) 2.89 (0.78) 2.89 (0.92) 2.81 (1.03)
Family 3.07 (0.91) 3.14 (0.72) 3.11 (0.78) 3.22 (0.83) 2.90 (1.17)
Social 2.13 (0.96) 2.29 (0.71) 2.11 (1.05) 2.00 (0.86) 2.05 (1.20)
Legal 1.08 (1.60) 1.38 (1.68) 0.67 (1.41) 0.44 (1.33) 1.24 (1.70)
Psychiatric 2.93 (0.95) 3.05 (0.49) 3.44 (0.72) 2.78 (1.39) 2.67 (1.11)
     
 N (%) N (%) N (%) N (%) N (%)
Tobacco      
No Use - (-) - (-) - (-) - (-) - (-)
Occasional Use 3 (.05) - (-) - (-) - (-) 3 (.14)
Regular Use 7 (.12) 1 (.05) - (-) 3 (.33) 3 (.14)
SUP 11 (.18) 3 (.14) 2 (.22) 3 (.33) 3 (.14)
SUD 39 (.65) 17 (.81) 7 (.78) 3 (.33) 12 (.57)
Alcohol     
No Use 2 (.03) 1 (.05) - (-) - (-) 1 (.05)
Occasional Use 16 (.26) 5 (.23) 5 (.55) - (-) 6 (.29)
Regular Use 16 (.26) 6 (.29) 1 (.11) 3 (.33) 6 (.29)
SUP 11 (.18) 2 (.10) 1 (.11) 3 (.33) 5 (.24)
SUD 15 (.25) 7 (.33) 2 (.22) 3 (.33) 3 (.15)
Cannabis     
No Use - (-) - (-) - (-) - (-) - (-)
Occasional Use 3 (.05) 1 (.05) - (-) 1 (.11) 1 (.05)
Regular Use 6 (.10) 3 (.14) - (-) 1 (.11) 2 (.10)
SUP 13 (.22) 5 (.24) 1 (.11) 2 (.22) 5 (.24)
SUD 38 (.63) 12 (.57) 8 (.88) 5 (.55) 13 (.62)
Other Drugs a      
No Use 26 (.43) 8 (.38) 6 (.67) - (-) 12 (.57)
Occasional Use 7 (.12) 2 (.10) 1 (.11) 1 (.11) 3 (.14)
Regular Use 5 (.08) 3 (.14) - (-) 1 (.11) 1 (.05)
SUP 7 (.12) 2 (.10) - (-) 2 (.22) 3 (.14)
SUD 15 (.25) 6 (.29) 2 (.22) 5 (.55) 2 (.10)
Note.
T-ASI (Teen Addiction Severity Index) domain range (0 None – 4 Extreme); SUP = Substance Use 
Problems; SUD = Substance Use Disorders; a mainly cocaine and amphetamine derivates; % = 
percentage related to each cluster.
Discriminant analysis 
Discriminant analysis was applied to assess the relative 
ability of different clinical scales of the MMPI-A to predict 
each patient’s membership of one of the clusters obtained. 
Box’s M test showed that the groups did not differ in their 
covariance matrices (Box’s M = 23.62 df = 18; p = .297), 
thereby fulfilling the assumption of homogeneity. Discrimi-
nant analysis  revealed three significant functions that were 
capable of assigning the patients to their correct cluster on 
the basis of only three scales: Depression (2 D), Psychopathic 
Deviate (4 Pd) and Psychasthenia (7 Pt). The first function 
(χ2 = 118.18, df = 9; p <= .001), explains the 82.7% of the 
variance and distinguishes patients with higher scores in 
the scales of 7 Pt y 4 Pd. These patients would be mainly 
assigned to cluster 1 or 2, whilst lower scores in this very 
function would be more prone join clusters 3 or 4. The second 
function (χ2 = 33.18, df = 4; p <= .001), explains the 15.7% 
of the variance and distinguishes patients with higher scores 
in the scale of 2 D and significant decrease in the scale 7 Pt; 
high scores in this function could help to discern between 
cluster 1 and 2. The third function (χ2 = 4.01, df = 1; p = 
.045), is marginally significant, providing as little explanation 
of global variance as  1.7%, and is noted for a weight decline 
of the scale 4 Pd, and a scale weight increase of the scale 
2 D. On the other hand, the rate of correct reclassification 
in each cluster (Table 4) was around 90% for clusters 1, 3 
and 4, but only 77.8% for the second cluster (disorganized-
conflictive), reallocating 22.2% of patients in cluster 1.
Discussion
This study of adolescents with SUD revealed a general 
MMPI-A profile similar to those obtained in other adoles-
cent and adult SUD samples (Gallucci, 1997; Walfish et al., 
1990), showing peaks on 4 Pd, 3 Hy and 2 D, although it 
lacked the typical increase on the 9 Ma scale. This could be 
explained by a high representation of females (52%) and of 
‘faking good’ profiles (35%) in our study, as well as by the 
clinical status of the sample, since high T scores on the 9 
Ma scale are more usual in male SUD adolescents from cor-
rectional settings (Archer, 2005). Moreover, the four clusters 
found in this study (1: acting out; 2: disorganized-conflictive;
3: normative-impulsive; and 4: deceptive-concealed) seemed 
to validate those obtained by Passetti (2002) and, to some 
extent, the three clusters obtained by Massey et al. (1992), 
with small differences due to methodological particularities. 
Table 4.  Discriminant Analysis observed groups and predicted 
membership (%)
Predicted groups
Observed Cluster 1 Cluster 2 Cluster 3 Cluster 4
groups (n = 21) (n = 9) (n = 9) (n = 21)
Cluster 1 “acting out” (n=21) 90.5% 9.5% 0% 0%
Cluster 2 “disorganized-conflictive”  (n=9) 22.2% 77.8% 0% 0%
Cluster 3 “normative-impulsive”  (n=9) 0% 0% 88.9% 11.1%
Cluster 4 “deceptive-concealed” (n=21) 4.8% 0% 0% 95.2%
Note.
Overall correct re-classification: 90%.
Table 3. Descriptive analysis of CBCL psychopathology and 
comorbid clinical diagnoses in general SUD
sample and the four clusters. 
Variables General SUD Cluster 1 Cluster 2 Cluster 3 Cluster 4
 sample (n=21)  (n=9)  (n=9) (n=21)
 (n = 60) “Acting “Disorganized- “Normative- “Deceptive-
  -Out” Conflictive” Impulsive” concealed”
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
CBCL
INT scale 65.54 (9.04) 64.06 (8.63) 73.38 (5.60) 64.86(9.56) 63.53 (9.20)
EXT scale 69.21 (7.62) 70.44(5.98) 71.13 (4.35) 68.57(10.48) 67.41 (8.98)
  
Comorbid N (%) N (%) N (%) N (%) N (%)
Diagnoses     
CD 9 (.15) 5 (0.24) - (-) 1 (.11) 3 (.14)
ODD 19 (.32) 10 (0.48) 1 (.11) 3 (.33) 5 (.24)
ADHD 12 (.20) 6 (0.29) 1 (.11) - (-) 5 (.24)
Anxiety 4 (.06) 2 (0.10) 2 (.22) - (-) - (-)
Depression 5 (.08) 2 (0.10) 1 (.11) 1 (.11) 1 (.05)
Psychotic 5 (.08) - (-) 3 (.33) 1 (.11) 1 (.05)
ED 12 (.20) 4 (0.19) 4 (.44) 2 (.22) 2 (.10)
Cluster B PD 12 (.20) 2 (0.10) 4 (.44) 3 (.33) 3 (.14)
Adjustment  6 (.10) 2 (0.10) - (-) 1 (.11) 3 (.14)
Other 7 (.12) 4 (0.19) - (-) - (-) 3 (.14)
Global  91 37 16 12 26
Note.
CBCL (Child Behavior Checklist) scales in T scores;  INT = Internalizing; EXT = Externalizing. 
Comorbid diagnoses: CD = Conduct disorder; ODD = Oppositional Defiant Disorder; ADHD = Attention 
Deficit Hyperactive Disorder; ED =Eating disorder; PD = Personality disorder; % = percentage related 
to each cluster.
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Lastly, discriminant analysis showed that three of the 
original ten clustering variables (2 D, 4 Pd and 7 Pt) had the 
greatest predictive ability as regards the cluster membership 
of patients. This suggests that a shorter version of the MMPI-
A might be used in adolescents with SUD to classify them 
into the clusters obtained.  Average correct reclassification (9 
of 10) provided by the discriminant was high within the four 
subgroups obtained. Discriminat analysis reveals that cluster 
reallocation shows less predicted consistency in cluster 2. In 
this case, 77.8% is attributed to the corresponding cluster, 
whereas a 22.2% were classified in cluster 1. This implies 
that patients in cluster 2 share some psychopathological 
characteristics with the acting-out cluster.
As expected, clusters did not differ either in the level of 
substance use or in the severity of addiction (T-ASI scales). 
Nevertheless, clear significant differences were found 
between clusters with respect to some drug-related MMPI-
A scales (MAC-R and ACK) and more subtle differences in 
PRO scale (p<0.05). These variables, reflecting mainly insight 
and/or proneness related to drug problems, are crucial in the 
design of appropriate interventions for SUD patients (Micuc-
ci, 2002). Regarding psychopathology, cluster 1 showed 
clinically significant T scores (>70) on the CBCL externalizing 
scale, and a significantly higher presence of ODD and CD as 
a primary or secondary diagnosis in addition to SUD. By con-
trast, cluster 2 showed clinically significant scores (T >70) 
on both the externalizing and the internalizing scales of the 
CBCL. These results corroborate those obtained in other stud-
ies (King et al., 2004; Martel et al., 2009) and point to the 
potential utility of assessing externalizing and internalizing 
symptoms in order to predict the risk for different subtypes 
of SUD, in order to design specific interventions (Winters, 
Stinchfield, Latimer & Stone, 2008). 
In relation to the above paragraph, some of the clusters 
found in this study are consistent with typologies of patients 
with alcohol or other SUD, suggesting at least two clear 
aetiological pathways for developing substance use problems 
(Babor, Hofmann, Del Boca, Hesselbrock, Meyer, Dolinsky et 
al., 1992; Sher, Grekin & Williams, 2005). Cluster 1 corre-
sponds to the antisocial or deviant proneness pathway and 
is associated with difficulties in impulse control and other 
frontal functions (Kirisci et al., 2007). Some authors have 
associated this type of SUD patient with externalizing symp-
toms (King et al., 2004; Winters et al. 2008) or with clus-
ter B personality disorders (Ball, Tennen, Poling Kranzler &
Rousanville, 1997). In alcoholic typologies, these patients are 
Cloninger type II or Babor type B (Babor et al., 1992). On the 
other hand, Cluster 2 in our study corresponds to the nega-
tive affect pathway (Sher et al., 2005), sometimes associated 
with mixed internalizing and externalizing symptoms (King 
et al., 2004) or with cluster C personality disorders (Ball et 
al., 1997). This cluster is similar to Cloninger type I or Babor 
type A alcoholics (Babor et al., 1992).
Various authors have suggested that SUD treatments 
which are tailored to address specific needs or underlying 
personality risk factors may lead to better outcomes (Conrod 
et al., 2010; Winters et al., 2008). Therefore, the analysis of 
MMPI-A cluster profiles and other clinical and drug-relat-
ed variables could help to make tentative cluster-specific 
therapeutic recommendations (Passetti, 2002). For exam-
ple, patients in Cluster 1 (acting-out) may need high moti-
vational input to increase their willingness to change their 
drug use, because they have no real insight into their drug 
problems and usually show poor therapeutic adherence. The 
introduction of family members into treatment is necessary 
to confront these patients with their real problems, and some 
resistant antisocial cases may need intensive case manage-
ment or correctional treatment settings (Hawkins, 2009; 
Liddle, Rowe, Dakof, Henderson & Greenbaum, 2009). Clus-
ter 2 patients (disorganized-conflictive) are usually chronic 
patients in need of intensive and flexible integrated treat-
ments (Martino et al., 2002), long-term follow-up and, in 
some cases, therapeutic residential programs (Hawkins, 2009; 
Waldron & Turner, 2008). They usually require psychophar-
macological treatment with antipsychotics, antidepressants 
or mood-stabilizers even before achieving abstinence, due 
to severe psychiatric symptoms that might otherwise lead to 
drug use for the purposes of self-medication (Kosten & Kos-
ten, 2004). By contrast, in Cluster 3 SUD adolescents (nor-
mative-impulsive), brief motivational interventions, psycho-
education and urine analyses to monitor drug use may be 
enough to avoid drug problems (Conrod et al., 2010).  Finally, 
Cluster 4 patients (deceptive-concealed), according to their 
‘fake good’ validity profile (Stein & Graham, 2005), mini-
mize their problems with drugs and try to drop out of treat-
ment early, after achieving only superficial changes. In these 
seductive adolescents the therapist must use complex moti-
vational, cognitive and family strategies to engage patients 
and break their erroneous schemas and narcissistic defenses 
(Beck et al., 2004, Calvete & Estévez, 2009). 
Strengths and limitations
The main strength of this study is the replication and 
validation of previously obtained clusters based on MMPI-
A scales, this time in a sample of dually diagnosed adoles-
cents. However, this study has several limitations. First, a 
larger sample would be desirable to show more consistent 
results. Second, participants in this study are probably not 
fully representative of dually disordered adolescents, because 
the proportion of females was similar to that of males. Third, 
this study is cross-sectional and it is not possible to discern 
whether psychopathological and personality characteristics 
are primary or secondary to SUD. 
This pilot study found four personality subtypes in ado-
lescent patients with dual diagnosis. The scales of depression, 
psychasthenia and psychopathic deviation of the MMPI-A 
made the best discrimination between the four subtypes of 
adolescents patients.
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